No Data
No Data
No Data
No Data
No Data
Propanc Undertakes 1-for-1000 Reverse Stock Split
Seeking AlphaMay 23, 2023 04:39 ET
Sidoti's November Micro-Cap Virtual Conference
Presentation Times and Weblinks Released for Over 35 Presenting CompaniesWednesday and Thursday, November 9-10, 2022NEW YORK, NY / ACCESSWIRE / November 8, 2022 / Sidoti & Company, LLC has release
AccesswireNov 8, 2022 15:45 ET
Propanc to Get EU Patent for Proenzyme Compositions to Treat Cancer
Propanc Biopharma (OTCQB:PPCB) said it received a notice of allowance from the European Patent Office (EPO) for claims involving compositions of proenzymes to treat cancer. The company added that it w
Seeking AlphaAug 16, 2022 09:50 ET
Propanc Biopharma's CEO Comments on the 39 Granted Patents and 26 Patent Applications Under Examination in Key Global Jurisdictions
Current Patents and Planned Future Patent Applications Covers the Company's Lead Product Candidate, PRP, and Backup Clinical Compounds Propanc Biopharma, Inc. (OTCQB:PPCB) ("Propanc" or the "Company"), a biopharmaceutical company developing novel can
BusinessWireJul 5, 2022 09:05 ET
Propanc Biopharma Announces No Immediate Plans For Reverse Stock Split >PPCB
Propanc Biopharma Announces No Immediate Plans For Reverse Stock Split >PPCB
Dow JonesJun 24, 2022 09:00 ET
No Data
No Data
101863715 : 怎么了
LiuYongkang : 有